Vaccines

Apr 20, 2015
By Pharmaceutical Technology Editors
GSK notifies CDC and FDA that it is recalling the remaining doses of its 2014–2015 flu vaccine, Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes, due to decreased potency.
Apr 03, 2015
By Pharmaceutical Technology Editors
GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.
Apr 02, 2015
By Pharmaceutical Technology Editors
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
Mar 26, 2015
FDA has approved another indication for Eylea, a treatment for diabetic retinopathy in patients with diabetic macular edema.
Mar 25, 2015
By Pharmaceutical Technology Editors
Emergent BioSolutions announced FDA approval of Anthrasil, an inhalable treatment that targets Anthrax toxins, as well as a contract with BARDA to develop NuThrax, an anthrax vaccine candidate.
Mar 24, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The agency provides guidance on determining the need for environmental assessments for gene therapies, vectored vaccines, and viral and microbial products.
Mar 06, 2015
The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.
Jan 23, 2015
Pharmaceutical Technology
Government and industry efforts to address manufacturing challenges move Ebola vaccine candidates into larger clinical trials.
Dec 15, 2014
Pharmaceutical Technology
The development and approval of new vaccines and antivirals to contain and treat the Ebola virus outbreak has become a top priority for the federal government and Congress, as seen in new policies to spur R&D and added funding for these efforts.
Dec 15, 2014
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Baxter announced that it had entered into an agreement to sell its Vero cell technology and related assets to Nanotherapeutics.
native1_300x100
lorem ipsum